K. N.
Impact in
-
- Cancer, Lipids, and Metabolism
-
- Clusterin in disease pathology
Papers in
-
- Prostate Cancer Treatment and Research 11
- Prostate Cancer Diagnosis and Treatment 4
- Oncology 12
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 3
- Clusterin in disease pathology 3
- Co-authors
- Martin Gleave (8 shared papers)Hideaki Miyake (1 shared paper)Anthony W. Tolcher (3 shared papers)Nicholas Murray (1 shared paper)C. Bryce (1 shared paper)Susan D’Aloisio (2 shared papers)Richard Klasa (1 shared paper)Christian Kollmannsberger (4 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Cancer Chemotherapy and Pharmacology (2 papers)Investigational New Drugs (1 paper)Current Oncology (1 paper)PubMed (2 papers)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
K. N.
21 papers receiving 503 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 144
- Oncology 208
- Pulmonary and Respiratory Medicine 213
- Molecular Biology 286
- Hematology 30
Countries citing papers authored by K. N.
This map shows the geographic impact of K. N.'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. N. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. N. more than expected).
Fields of papers citing papers by K. N.
This network shows the impact of papers produced by K. N.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. N.. The network helps show where K. N. may publish in the future.
Co-authors
The 25 scholars most cited alongside K. N., linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer. | 2001 | 156 |
| 2 | Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. | 2000 | 129 |
| 3 | 2015 | 54 | |
| 4 | 2012 | 28 | |
| 5 | 2012 | 27 | |
| 6 | 2010 | 15 | |
| 7 | 2004 | 14 | |
| 8 | 2005 | 14 | |
| 9 | 2009 | 13 | |
| 10 | 2011 | 12 | |
| 11 | 2005 | 12 | |
| 12 | 2009 | 6 | |
| 13 | 2007 | 6 | |
| 14 | 2005 | 5 | |
| 15 | 2019 | 3 | |
| 16 | 2004 | 3 | |
| 17 | 2004 | 3 | |
| 18 | 2011 | 3 | |
| 19 | 2006 | 2 | |
| 20 | 2007 | 2 |
About K. N.
K. N. is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 21 papers that have together received 509 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Clusterin in disease pathology (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Glutathione Transferases and Polymorphisms (2 papers). The work is most often cited by research in Cancer Research (144 citations), Oncology (208 citations), Pulmonary and Respiratory Medicine (213 citations), Molecular Biology (286 citations) and Hematology (30 citations). K. N. has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include Martin Gleave, Hideaki Miyake, Anthony W. Tolcher, Nicholas Murray, C. Bryce, Susan D’Aloisio, Richard Klasa, Christian Kollmannsberger, Jean Powers and Holger W. Hirte. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Investigational New Drugs, Current Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.